5-(Trifluoromethyl)nicotinic acid, 97.0%, 1g

imidazolidine-2,4-dione, >98%, 100g

4-Chloro-2-methoxyquinoline, 95.0%, 250mg

(R)-1,1,1-Trifluoro-2-pentylamine, 98.0%, 5g

2-[(dimethylamino)methyl]benzoic acid, 95.0%, 5g

2-(4-Methylphenyl)-1,3-thiazole-4-carboxylic acid, 97.0%, 100mg

3-Bromo-6-chloro-1-tetrahydropyran-2-yl-pyrazolo[4,3-c]pyridine, 98%, 100mg

Stativringe mit Öffnung Variante, Ø innen (mm) 70, Ø außen (mm), 87, Öffnung (mm), 50, Gesamtlänge (mm), 280, Schaftlänge (mm), 200, VE. (Stücke),1

6-(4-t-Butylphenyl)-6-oxohexanoic acid, 97.0%, 1g

4-Chloro-3-hydroxybenzotrifluoride, 98.0%, 1g

1-({amino[(4-chlorophenyl)amino]methylidene}amino)-N-(propan-2-yl)methanimidamide, 97%, 10g

2,2,2-Trifluoro-1-(3-fluoropyridin-2-yl)ethanone, 95.0%, 1g

2,5-Dioxopyrrolidin-1-yl hexanoate, 95%, 100mg